Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.

A team of researchers at UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and potentially reverse, immune checkpoint inhibitor (ICI)–induced type I ...

The compound, which showed oral bioavailability of 42.7%, performed similarly well as the licensed drug loratidine in a mouse model of the inflammatory disease allergic rhinitis.

Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.The discovery could lead to the ...

Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...